Will This Analyst Upgrade Help Envision Healthcare (EVHC) Stock Today?

NEW YORK (TheStreet) -- Goldman Sachs upgraded Envision Healthcare  (EVHC) to "buy" from "neutral," set a $43 price target and placed the stock on its Conviction List. The firm noted the company's outlook is improving and it trades at a compelling valuation.

The stock closed at $35.95 on Friday.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EVHC Chart

EVHC data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Netflix Tanks After Weak Subscriber Growth in 'Strong but not Stellar' Q2

Netflix Tanks After Weak Subscriber Growth in 'Strong but not Stellar' Q2

Stocks Fall Ahead of Fed Chair's First Congressional Testimony

Stocks Fall Ahead of Fed Chair's First Congressional Testimony

Goldman Profit Jumps 40% as CEO Blankfein Prepares to Step Down

Goldman Profit Jumps 40% as CEO Blankfein Prepares to Step Down

Goldman Sachs' Quarter Was Too Darn Strong Not to Send Stock Exploding

Goldman Sachs' Quarter Was Too Darn Strong Not to Send Stock Exploding

Video: What Goldman Sachs's CEO Change Means for Banking Stocks

Video: What Goldman Sachs's CEO Change Means for Banking Stocks